Femaralyn 2.5 mg (Letrozole) – 50 Tablets
Buy Letrozole 2.5 mg Online in Portugal & Europe
Femaralyn 2.5 mg contains Letrozole, a third-generation non-steroidal aromatase inhibitor (AI). It is used clinically to reduce estrogen production and is prescribed primarily for the treatment of hormone receptor-positive breast cancer. In sports medicine, it is sometimes used under medical supervision to manage elevated estradiol associated with aromatizable anabolic steroids.
Product Highlights
2.5 mg Letrozole per tablet
50 tablets per bottle
Oral administration
Third-generation aromatase inhibitor (AI)
Potent suppression of estrogen production
Manufactured by Driada Medical
Potential Benefits
Helps reduce excessive estrogen production
Supports management of elevated estradiol under medical supervision
May reduce the risk of estrogen-related side effects such as gynecomastia when clinically indicated
May reduce water retention associated with elevated estrogen
Can support hormonal management in selected medical situations
Product Information
Active Ingredient: Letrozole
Strength: 2.5 mg per tablet
Quantity: 50 tablets
Form: Oral tablets
Brand: Driada Medical
Category: Aromatase Inhibitor (AI)
How It Works
Letrozole inhibits the aromatase enzyme, which converts androgens into estrogens. By reducing aromatase activity, circulating estrogen levels decrease.
In clinical practice, this mechanism is used primarily for the treatment of hormone-sensitive breast cancer. Any use for hormone management outside approved indications should only occur under appropriate medical supervision with laboratory monitoring.
Medical Uses
Letrozole is approved in many countries for:
Hormone receptor-positive breast cancer in postmenopausal women
Off-label uses may exist but should only be considered by qualified healthcare professionals.
Possible Side Effects
Potential adverse effects include:
Joint pain (arthralgia)
Muscle aches
Fatigue
Hot flashes
Headache
Decreased libido
Mood changes
Reduced bone mineral density with prolonged use
Adverse changes in cholesterol levels
Excessive estrogen suppression may negatively affect:
Joint health
Bone health
Mood
Sexual function
Cardiovascular health
Pharmacological Profile
Compound: Letrozole
Class: Aromatase Inhibitor (AI)
Administration: Oral
Approximate Half-life: 2–4 days
Storage
Store at room temperature.
Keep in a cool, dry place.
Protect from direct sunlight.
Keep out of reach of children.
Important Information
Letrozole is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Hormone levels should be monitored with appropriate laboratory testing to avoid excessive estrogen suppression and its associated risks. Use only where legally permitted and according to local regulations.
Buy Letrozole 2.5 mg Online in Portugal & Europe
Femaralyn 2.5 mg contains Letrozole, a third-generation non-steroidal aromatase inhibitor (AI). It is used clinically to reduce estrogen production and is prescribed primarily for the treatment of hormone receptor-positive breast cancer. In sports medicine, it is sometimes used under medical supervision to manage elevated estradiol associated with aromatizable anabolic steroids.
Product Highlights
2.5 mg Letrozole per tablet
50 tablets per bottle
Oral administration
Third-generation aromatase inhibitor (AI)
Potent suppression of estrogen production
Manufactured by Driada Medical
Potential Benefits
Helps reduce excessive estrogen production
Supports management of elevated estradiol under medical supervision
May reduce the risk of estrogen-related side effects such as gynecomastia when clinically indicated
May reduce water retention associated with elevated estrogen
Can support hormonal management in selected medical situations
Product Information
Active Ingredient: Letrozole
Strength: 2.5 mg per tablet
Quantity: 50 tablets
Form: Oral tablets
Brand: Driada Medical
Category: Aromatase Inhibitor (AI)
How It Works
Letrozole inhibits the aromatase enzyme, which converts androgens into estrogens. By reducing aromatase activity, circulating estrogen levels decrease.
In clinical practice, this mechanism is used primarily for the treatment of hormone-sensitive breast cancer. Any use for hormone management outside approved indications should only occur under appropriate medical supervision with laboratory monitoring.
Medical Uses
Letrozole is approved in many countries for:
Hormone receptor-positive breast cancer in postmenopausal women
Off-label uses may exist but should only be considered by qualified healthcare professionals.
Possible Side Effects
Potential adverse effects include:
Joint pain (arthralgia)
Muscle aches
Fatigue
Hot flashes
Headache
Decreased libido
Mood changes
Reduced bone mineral density with prolonged use
Adverse changes in cholesterol levels
Excessive estrogen suppression may negatively affect:
Joint health
Bone health
Mood
Sexual function
Cardiovascular health
Pharmacological Profile
Compound: Letrozole
Class: Aromatase Inhibitor (AI)
Administration: Oral
Approximate Half-life: 2–4 days
Storage
Store at room temperature.
Keep in a cool, dry place.
Protect from direct sunlight.
Keep out of reach of children.
Important Information
Letrozole is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Hormone levels should be monitored with appropriate laboratory testing to avoid excessive estrogen suppression and its associated risks. Use only where legally permitted and according to local regulations.